Carrazco-Montalvo Andrés, Gutiérrez-Pallo Diana, Arévalo Valentina, Ponce Patricio, Rodríguez-Polit Cristina, Echeverría-Garcés Gabriela, Coloma Josefina, Nipaz Victoria, Cevallos Varsovia
Centro de Referencia Nacional de Genómica, Secuenciación y Bioinformática (GENSBIO), Instituto Nacional de Investigación en Salud Pública (INSPI), Quito 170403, Ecuador.
Centro de Investigación en Enfermedades Infecciosas y Vectoriales (CIREV), Instituto Nacional de Investigación en Salud Pública (INSPI), Quito 170403, Ecuador.
Pathogens. 2025 May 28;14(6):541. doi: 10.3390/pathogens14060541.
Ecuador, a tropical country with frequent dengue outbreaks, including a surge from 16,017 cases in 2022 to 61,329 in 2024, was the focus of this study. The study was conducted in Borbon, a semi-urban rural town in the Esmeraldas province. Genomic analysis, alongside entomo-virological surveillance, provides valuable insights into DENV-2 genotypes. Five pools of female mosquitoes from Borbon tested positive for DENV serotype 2 through RT-qPCR. One positive pool (CT = 16.13) was sequenced using Illumina MiSeq, and genotyping was conducted via the Dengue Typing Tool and Maximum Likelihood phylogenetic tree. The genotype assigned was III Southern Asian-American. Comparison with other genomes revealed genetic similarity to a human dengue genome sequenced in 2021, also from Esmeraldas, clustering with genomes reported across the Americas, particularly from Colombia and Venezuela. This study enhances our understanding of dengue virus epidemiology in rural areas, emphasizing the critical role of clinical case surveillance and vector monitoring in guiding evidence-based interventions.
厄瓜多尔是一个热带国家,登革热疫情频发,病例数从2022年的16017例激增至2024年的61329例,该国是本研究的重点。研究在埃斯梅拉达斯省的一个半城郊镇博尔邦进行。基因组分析与昆虫病毒学监测一起,为登革病毒2型基因型提供了有价值的见解。通过逆转录定量聚合酶链反应(RT-qPCR)检测,来自博尔邦的五组雌性蚊子登革病毒血清型2呈阳性。使用Illumina MiSeq对一个阳性样本池(CT = 16.13)进行测序,并通过登革热分型工具和最大似然系统发育树进行基因分型。确定的基因型为III南亚-美洲型。与其他基因组的比较显示,其与2021年在埃斯梅拉达斯测序的一个人类登革热基因组具有遗传相似性,与美洲各地报告的基因组聚类,特别是来自哥伦比亚和委内瑞拉的基因组。本研究增进了我们对农村地区登革热病毒流行病学的理解,强调了临床病例监测和病媒监测在指导循证干预措施方面的关键作用。